Roivant Sciences to Discontinue RVT-2001 Development in Myelodysplastic Syndrome

Investigation of RVT-2001 will be discontinued following an insufficient display of benefit in patients with myelodysplastic syndrome.

Related Keywords

Matt Gline ,Roivant Sciences ,International Prognostic Scoring System ,Mds ,Lower Risk Mds ,Myelodysplastic Syndrome ,Rvt 2001 ,Discontinued ,